Citations

Clear

2286 citation(s) found for "Yu, Anthony".

Ultrastructural Pathology of Neurofibrillary Tangles in Transgenic Mice Carrying Mutant (P301l) Human Tau Gene
Lin, W-L, Lewis, Jada , Corral, Anthony, Lin, W-L, Dickson, Dennis W. , Hutton, M.

Mayo Clinic

Microscopy and Microanalysis | July 2, 2020 | Volume: 6 | Issue: S2 | Pages: 584-585

10.1017/s1431927600035418 Get It

Abstract Tau is a microtubule-associated protein that promotes polymerization and stabilization of microtubules. It is the major component of fibrillary neuronal and glial inclusions in Alzheimer's disease (AD) and the tauopathies. An autosomal dominant familial tauopathy, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), has been shown to be caused by pathogenic tau mutations. Neuropathologic features of FTDP-17 are filamentous tau aggregates in neurons and glia. Previous transgenic mice carrying the normal human tau gene developed motor neuron disease and had dystrophic axons, but no neurofibrillary tangles (NFT). In this report we describe ultrastructural features of NFT in transgenic mice carrying a mutant human tau gene. The mice were generated with a tau cDNA containing exon 1, 4, 5, 7, 9, 10, 11-13, intron 13 and exon 14, driven by the mouse prion promoter (MoPrP) and containing the most common FTDP-17 mutation, P301L. The transgenic construct was generated by ligating the P301L tau cDNA with the mouse prion promoter.
Seizures in Children
Fine, Anthony L. , Wirrell, Elaine C., Fine, Anthony , Wirrell, Elaine

Mayo Clinic

Pediatrics In Review | July 1, 2020 | Volume: 41 | Issue: 7 | Pages: 321-347

10.1542/pir.2019-0134 | PMID 32611798 Get It

Epilepsy is one of the most common neurologic disorders seen in children, with the highest incidence in the first year of life. Diagnostic accuracy can be challenging because many seizure mimics must be considered. Electroencephalography and neuroimaging can be critical in determining etiology and syndrome. Genetic testing is a high-yield endeavor, particularly in early-life epilepsies. Up to one-fourth of children with epilepsy will develop drug-resistant seizures. Comorbidities are very common in children with epilepsy, including intellectual disability in 25% and learning disability and attention-deficit/hyperactivity disorder in a significant minority. These comorbidities must be recognized and addressed as part of the child’s overall care.
Variation in Fluid and Vasopressor Use in Shock With and Without Physiologic Assessment: A Multicenter Observational Study
Chen, Jen‐Ting , Roberts, Russel J. , Qadir, Nida , Cairns, Charles B. , Mathews, Kusum S. , Park, Pauline, Khan, Akram , Gilmore, James F. , Brown, Anne Rain , Tsuei, Betty J., Handzel, Michele, Chang, Alfredo Lee, Herbert, James T. , Martinez, Anthony , Tonna, Joseph E. , Nazer, Lama , Heavner, Mojdeh S. , Pender, Erin, Chambers, Lauren, Kenes, Michael T. , Kaufman, David A. , Downey, April, Chaykosky, Darlene, Wolff, Armand, Smith, Michael , Nault, Katie, Sevransky, Jonathan, Gong, Michelle N. , Network, on behalf of the VOLUME-CHASERS Study Group and Society of Critical Care Medicine Discovery, Tonna, Joseph E. , Heavner, Mojdeh S , Khan, Akram , Fazzari, Melissa J. , Kashani, Kianoush , Park, Pauline K. , Duggal, Abhijit , Lanspa, Michael J. , Ammar, Mahmoud A , Hammond, Drayton A , Brown, Brent , Network, on behalf of the VOLUME-CHASERS Study Group and Society of Critical Care Medicine Discovery

Mayo Clinic

Critical Care Medicine | June 30, 2020 | Volume: 48 | Issue: 10 | Pages: 1436-1444

10.1097/ccm.0000000000004429 | PMID 32618697 Get It

Objectives: To characterize the association between the use of physiologic assessment (central venous pressure, pulmonary artery occlusion pressure, stroke volume variation, pulse pressure variation, passive leg raise test, and critical care ultrasound) with fluid and vasopressor administration 24 hours after shock onset and with in-hospital mortality. Design: Multicenter prospective cohort study between September 2017 and February 2018. Settings: Thirty-four hospitals in the United States and Jordan. Patients: Consecutive adult patients requiring admission to the ICU with systolic blood pressure less than or equal to 90 mm Hg, mean arterial blood pressure less than or equal to 65 mm Hg, or need for vasopressor. Interventions: None. Measurement and Main Results: Of 1,639 patients enrolled, 39% had physiologic assessments. Use of physiologic assessment was not associated with cumulative fluid administered within 24 hours of shock onset, after accounting for baseline characteristics, etiology and location of shock, ICU types, Acute Physiology and Chronic Health Evaluation III, and hospital (beta coefficient, 0.04; 95% CI, −0.07 to 0.15). In multivariate analysis, the use of physiologic assessment was associated with a higher likelihood of vasopressor use (adjusted odds ratio, 1.98; 95% CI, 1.45−2.71) and higher 24-hour cumulative vasopressor dosing as norepinephrine equivalent (beta coefficient, 0.37; 95% CI, 0.19−0.55). The use of vasopressor was associated with increased odds of in-hospital mortality (adjusted odds ratio, 1.88; 95% CI, 1.27−2.78). In-hospital mortality was not associated with the use of physiologic assessment (adjusted odds ratio, 0.86; 95% CI, 0.63−1.18). Conclusions: The use of physiologic assessment in the 24 hours after shock onset is associated with increased use of vasopressor but not with fluid administration.
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial
Tamura, Manjula Kurella , Gaussoin, Sarah A. , Chelune, Gordon J. , Gure, Tanya R. , Haley, William E. , Killeen, Anthony A. , Oparil, Suzanne , Rapp, Stephen R. , Supiano, Mark A. , Williamson, Jeff D. , Kurella Tamura, Manjula , Haley, William E , Killeen, Anthony A , Supiano, Mark A , Pajewski, Nicholas M. , Freedman, Barry I. , Rifkin, Dena E. , Weiner, Daniel E.

Mayo Clinic

Journal of the American Society of Nephrology | June 26, 2020 | Volume: 31 | Issue: 9 | Pages: 2122-2132

10.1681/asn.2020010038 | PMID 32591439 Get It

Significance Statement Intensive treatment of hypertension is beneficial for cardiovascular disease and cognitive function, but at the short-term expense of reduced kidney function. In a randomized trial of intensive versus standard systolic BP lowering, the authors found an association between a large decline in eGFR and increased incidence of probable dementia and mild cognitive impairment, but no link between urinary albumin-to-creatinine ratio and occurrence of dementia or mild cognitive impairment. Decline in eGFR occurred more frequently in the intensive treatment group, but did not modify the beneficial effect of intensive treatment on cognitive function. Among hypertensive adults, declining eGFR may be a marker for those at higher risk for dementia or mild cognitive impairment, independent of the intensity of hypertension treatment. Background Intensively treating hypertension may benefit cardiovascular disease and cognitive function, but at the short-term expense of reduced kidney function. Methods We investigated markers of kidney function and the effect of intensive hypertension treatment on incidence of dementia and mild cognitive impairment (MCI) in 9361 participants in the randomized Systolic Blood Pressure Intervention Trial, which compared intensive versus standard systolic BP lowering (targeting <120 mm Hg versus <140 mm Hg, respectively). We categorized participants according to baseline and longitudinal changes in eGFR and urinary albumin-to-creatinine ratio. Primary outcomes were occurrence of adjudicated probable dementia and MCI. Results Among 8563 participants who completed at least one cognitive assessment during follow-up (median 5.1 years), probable dementia occurred in 325 (3.8%) and MCI in 640 (7.6%) participants. In multivariable adjusted analyses, there was no significant association between baseline eGFR <60 ml/min per 1.73 m 2 and risk for dementia or MCI. In time-varying analyses, eGFR decline ≥30% was associated with a higher risk for probable dementia. Incident eGFR <60 ml/min per 1.73 m 2 was associated with a higher risk for MCI and a composite of dementia or MCI. Although these kidney events occurred more frequently in the intensive treatment group, there was no evidence that they modified or attenuated the effect of intensive treatment on dementia and MCI incidence. Baseline and incident urinary ACR ≥30 mg/g were not associated with probable dementia or MCI, nor did the urinary ACR modify the effect of intensive treatment on cognitive outcomes. Conclusions Among hypertensive adults, declining kidney function measured by eGFR is associated with increased risk for probable dementia and MCI, independent of the intensity of hypertension treatment.
Localized, ANCA-Negative, Granulomatosis With Polyangiitis Presenting as Isolated Pulmonary Lesions
Dolomisiewicz, Anthony C., Redford, Albert H., Trost, Jaren R., Muruganadam, Maheswari, Martin, David R., Franklin, Michael M., Smith, Maxwell L., Emil, N. Suzanne, Dolomisiewicz, Anthony C., Redford, Albert H., Trost, Jaren R., Muruganadam, Maheswari, Martin, David R., Franklin, Michael M., Smith, Maxwell L., Emil, N. Suzanne

Mayo Clinic

JCR: Journal of Clinical Rheumatology | June 20, 2020 | Volume: 27 | Issue: 8S | Pages: S800-S803

10.1097/rhu.0000000000001454 | PMID 32568953 Get It

Effect of Anatomic Segment Involvement on Stereotactic Radiosurgery for Facial Nerve Schwannomas: An International Multicenter Cohort Study
Mehta, Gautam U. , Leković, Gregory P. , Slattery, William H. , Brackmann, Derald E., Long, Hao , Kano, Hideyuki , Mureb, Monica , Bernstein, Kenneth , Langlois, Anne-Marie, Mathieu, David , Nabeel, Ahmed M. , Reda, Wael A. , Tawadros, Sameh R. , Abdelkarim, Khaled , El-Shehaby, Amr M. N. , Emad, Reem M. , Mohammed, Nasser , Urgošík, Dušan, Liščák, Roman , Lee, Cheng‐Chia , Montazeripouragha, Amanallah , Joshi, Krishna C. , Barnett, Gene H. , Lunsford, L. Dade , Sheehan, Jason P. , Mehta, Gautam U , Mathieu, David , Kondziolka, Douglas , Langlois, Anne-Marie, Reda, Wael A. , Yang, Huai‐Che , Kaufmann, Anthony M. , Trifiletti, Daniel M.

Mayo Clinic

Neurosurgery | June 19, 2020 | Volume: 88 | Issue: 1 | Pages: E91-E98

10.1093/neuros/nyaa313 | PMID 32687577 Get It

Abstract BACKGROUND Facial nerve schwannomas are rare, challenging tumors to manage due to their nerve of origin. Functional outcomes after stereotactic radiosurgery (SRS) are incompletely defined. OBJECTIVE To analyze the effect of facial nerve segment involvement on functional outcome for these tumors. METHODS Patients who underwent single-session SRS for facial nerve schwannomas with at least 3 mo follow-up at 11 participating centers were included. Preoperative and treatment variables were recorded. Outcome measures included radiological tumor response and neurological function. RESULTS A total of 63 patients (34 females) were included in the present study. In total, 75% had preoperative facial weakness. Mean tumor volume and margin dose were 2.0 ± 2.4 cm 3 and 12.2 ± 0.54 Gy, respectively. Mean radiological follow-up was 45.5 ± 38.9 mo. Progression-free survival at 2, 5, and 10 yr was 98.1%, 87.2%, and 87.2%, respectively. The cumulative proportion of patients with regressing tumors at 2, 5, and 10 yr was 43.1%, 63.6%, and 63.6%, respectively. The number of involved facial nerve segments significantly predicted tumor progression ( P = .04). Facial nerve function was stable or improved in 57 patients (90%). Patients with involvement of the labyrinthine segment of the facial nerve were significantly more likely to have an improvement in facial nerve function after SRS ( P = .03). Hearing worsened in at least 6% of patients. Otherwise, adverse radiation effects included facial twitching (3 patients), facial numbness (2 patients), and dizziness (2 patients). CONCLUSION SRS for facial nerve schwannomas is effective and spares facial nerve function in most patients. Some patients may have functional improvement after treatment, particularly if the labyrinthine segment is involved.
How Will Machine Learning Inform the Clinical Care of Atrial Fibrillation?
Siontis, Konstantinos C. , Pirruccello, James P. , Philippakis, Anthony , Yao, Xiaoxi , Noseworthy, Peter A.

Mayo Clinic

Circulation Research | June 18, 2020 | Volume: 127 | Issue: 1 | Pages: 155-169

10.1161/circresaha.120.316401 | PMID 32833571 Get It

Machine learning applications in cardiology have rapidly evolved in the past decade. With the availability of machine learning tools coupled with vast data sources, the management of atrial fibrillation (AF), a common chronic disease with significant associated morbidity and socioeconomic impact, is undergoing a knowledge and practice transformation in the increasingly complex healthcare environment. Among other advances, deep-learning machine learning methods, including convolutional neural networks, have enabled the development of AF screening pathways using the ubiquitous 12-lead ECG to detect asymptomatic paroxysmal AF in at-risk populations (such as those with cryptogenic stroke), the refinement of AF and stroke prediction schemes through comprehensive digital phenotyping using structured and unstructured data abstraction from the electronic health record or wearable monitoring technologies, and the optimization of treatment strategies, ranging from stroke prophylaxis to monitoring of antiarrhythmic drug (AAD) therapy. Although the clinical and population-wide impact of these tools continues to be elucidated, such transformative progress does not come without challenges, such as the concerns about adopting black box technologies, assessing input data quality for training such models, and the risk of perpetuating rather than alleviating health disparities. This review critically appraises the advances of machine learning related to the care of AF thus far, their potential future directions, and its potential limitations and challenges.
Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial
Meschia, James F. , Walton, Ronald L., Farrugia, Luca, Ross, Owen A. , Elm, Jordan J. , Farrant, Mary, Meurer, William J. , Lindblad, Anne S., Barsan, William G. , Ching, Marilou, Gentile, Nina , Ross, Michael A., Kim, Anthony S., Zurita, Karla G. , Cucchiara, Brett , Johnston, S. Claiborne , Kim, Anthony , Farrugia, Luca P, Meschia, James F , Ross, Owen A , Cucchiara, Brett L , Kim, Anthony S , Nahab, Fadi B , Easton, J. Donald , Kim, Anthony S.

Mayo Clinic

Stroke | June 17, 2020 | Volume: 51 | Issue: 7 | Pages: 2058-2065

10.1161/strokeaha.119.028713 | PMID 32568642 Get It

Background and Purpose: Clopidogrel is an antiplatelet drug that is metabolized to its active form by the CYP2C19 enzyme. The CHANCE trial (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) found a significant interaction between loss-of-function allele status for the CYP2C19 gene and the effect of dual antiplatelet therapy with aspirin and clopidogrel on the rate of early recurrent stroke following acute transient ischemic attack/minor stroke. The POINT (Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial), similar in design to CHANCE but performed largely in North America and Europe, demonstrated a reduction in early recurrent stroke with dual antiplatelet therapy compared with aspirin alone. This substudy was done to evaluate a potential interaction between loss-of-function CYP2C19 alleles and outcome by treatment group in POINT. Methods: Of the 269 sites in 10 countries that enrolled patients in POINT, 134 sites participated in this substudy. DNA samples were genotyped for CYP2C19 *2, *3, and *17 alleles and classified as being carriers or noncarriers of loss-of-function alleles. Major ischemia consisted of ischemic stroke, myocardial infarction, or ischemic vascular death. Results: Nine hundred thirty-two patients provided analyzable DNA. The rates of major ischemia were 6.7% for the aspirin group versus 2.3% for the dual antiplatelet therapy group (hazard ratio, 0.33 [95% CI, 0.09–1.21]; P =0.09) among carriers of loss-of-function allele. The rates of major ischemia were 5.6% for the aspirin group versus 3.7% for the dual antiplatelet therapy group (hazard ratio, 0.65 [95% CI, 0.32–1.34]; P =0.25) among noncarriers. There was no significant interaction by genotype for major ischemia ( P =0.36) or stroke ( P =0.33). Conclusions: This substudy of POINT found no significant interaction with CYP2C19 loss-of-function carrier status and outcome by treatment group. Failure to confirm the findings from the CHANCE trial may be because the loss-of-function alleles tested are not clinically important in this context or because the 2 trials had differences in racial/ethnic composition. Additionally, differences between the 2 trials might be due to chance as our statistical power was limited to 50%. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT00991029.
Anti-fibrotic effects of the antihistamine ketotifen in a rabbit model of arthrofibrosis
Tibbo, Meagan E. , Limberg, Afton K. , Salib, Christopher G. , Turner, Travis W., McLaury, Alex R., Bettencourt, Jacob W. , Carter, Jodi M. , Berry, Daniel J, Wijnen, André J. van , Berry, Daniel J. , Jay, Anthony G. , Sanchez-Sotelo, Joaquin, van Wijnen, Andre J , Berry, Daniel J , Carter, Jodi , Bolon, Brad , Berry, Daniel J, Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Abdel, Matthew P.

Mayo Clinic

Bone & Joint Research | June 17, 2020 | Volume: 9 | Issue: 6 | Pages: 302-310

10.1302/2046-3758.96.bjr-2019-0272.r2 | PMID 32728431 Get It

Aims Arthrofibrosis is a relatively common complication after joint injuries and surgery, particularly in the knee. The present study used a previously described and validated rabbit model to assess the biomechanical, histopathological, and molecular effects of the mast cell stabilizer ketotifen on surgically induced knee joint contractures in female rabbits. Methods A group of 12 skeletally mature rabbits were randomly divided into two groups. One group received subcutaneous (SQ) saline, and a second group received SQ ketotifen injections. Biomechanical data were collected at eight, ten, 16, and 24 weeks. At the time of necropsy, posterior capsule tissue was collected for histopathological and gene expression analyses (messenger RNA (mRNA) and protein). Results At the 24-week timepoint, there was a statistically significant increase in passive extension among rabbits treated with ketotifen compared to those treated with saline (p = 0.03). However, no difference in capsular stiffness was detected. Histopathological data failed to demonstrate a decrease in the density of fibrous tissue or a decrease in α-smooth muscle actin (α-SMA) staining with ketotifen treatment. In contrast, tryptase and α-SMA protein expression in the ketotifen group were decreased when compared to saline controls (p = 0.007 and p = 0.01, respectively). Furthermore, there was a significant decrease in α-SMA (ACTA2) gene expression in the ketotifen group compared to the control group (p < 0.001). Conclusion Collectively, these data suggest that ketotifen mitigates the severity of contracture formation in a rabbit model of arthrofibrosis. Cite this article: Bone Joint Res 2020;9(6):302–310.
Serial Perioperative Assessment of Free Flap Perfusion With Laser Angiography
Massaro, Anthony F., Gómez, Juliana , Weyh, Ashleigh , Bunnell, A., Warrick, Matthew, Pirgousis, Philip, Fernandes, Rui , Weyh, Ashleigh Michelle , Massaro, Anthony, Pirgousis, Phil

Mayo Clinic

Craniomaxillofacial Trauma & Reconstruction | June 15, 2020 | Volume: 14 | Issue: 1 | Pages: 16-22

10.1177/1943387520930608 | PMID 33613831 Get It

Study Design: Prospective cohort study. Objective: Reconstruction with microvascular free flaps is quite predictable but excessive fluids intraoperatively and excessive use of vasopressors have been implicated in postoperative complications. However, vasopressors assist in limiting fluid administration and counteract vasodilatory effects of general anesthetics, while maintaining proper intravascular volume. This is of paramount importance during surgery to ensure adequate tissue and organ perfusion. The purpose of this study is to quantify perfusion changes in free flaps at specific time points during peri- and postoperative periods, incorporating SPY technology. Methods: A prospective study of patients who underwent free flap reconstruction was conducted (n = 9), using SPY laser angiography with indocyanine green to assess effects of general anesthetics and vasopressors on flap perfusion. Free flaps were evaluated prior to pedicle division, after inset and anastomosis, and in the immediate postoperative setting. Mean perfusion, mean arterial pressure, total operative time, fluid shifts, and vasopressor use were recorded. Data were analyzed with univariate and multivariable analyses. Results: Those with major complications in this cohort, on average received less vasopressors, had shorter operation times and less blood loss, however, they received more fluids intraoperatively. Conclusion: Changes in mean perfusion to the free flap during the intraoperative and immediate postoperative period are nominal.